Nanotech and synbio: Americans don't know what's comingSeptember 30, 2008Landmark poll shows little knowledge of emerging technologies Washington, DC -- A groundbreaking poll finds that almost half of U.S. adults have heard nothing about nanotechnology, and nearly nine in 10 Americans say they have heard just a little or nothing at all about the emerging field of synthetic biology, according to a new report released by the Project on Emerging Nanotechnologies (PEN) and Peter D. Hart Research. Both technologies involve manipulating matter at an incredibly small scale to achieve something new. This new insight into limited public awareness of emerging technologies comes as a major leadership change is about to take hold in the nation's capital. Public policy experts are concerned, regardless of party, that the federal government is behind the curve in engaging citizens on the potential benefits and risks posed by technologies that could have a significant impact on society.
"Early in the administration of the next president, scientists are expected to take the next major step toward the creation of synthetic forms of life. Yet the results from the first U.S. telephone poll about synthetic biology show that most adults have heard just a little or nothing at all about it," says PEN Director David Rejeski. The poll findings are contained a report published today, The American Public's Awareness Of And Perceptions About Potential Risks and Benefits of Nanotechnology & Synthetic Biology, and available at: http://www.nanotechproject.org/n/synbio_poll . This page is limited access until the embargo is lifted. Login: synbio Password: advance Synthetic biology is the use of advanced science and engineering to construct or re-design living organisms--like bacteria--so that they can carry out specific functions. This emerging technology is likely to develop rapidly in the coming years, much as nanotechnology did in the last decade. In the near future the first synthetic biology "blockbuster" drug is anticipated to hit the market--an affordable treatment for the 500 million people in the world suffering from malaria. The poll, which was conducted by the same firm that produces the well-known NBC News/Wall Street Journal polls, found that about two-thirds of adults say they have heard nothing at all about synthetic biology, and only 2 percent say they have heard "a lot" about the new technology. Even with this very low level of awareness, a solid two-thirds of adults are willing to express an initial opinion on the potential benefits versus risks tradeoff of synthetic biology. This survey was informed by two focus groups conducted in August in suburban Baltimore. This is the first time--to the pollsters' knowledge--that synthetic biology has been the subject of a representative national telephone survey. At the same time, the poll found that about half of adults say they have heard nothing at all about nanotechnology. About 50 percent of adults are too unsure about nanotechnology to make an initial judgment on the possible tradeoffs between benefits and risks. Of those people who are willing to make an initial judgment, they think benefits will outweigh risks by a three to one margin when compared to those who believe risks will outweigh benefits. The plurality of respondents, however, believes that risks and benefits will be about equal. A major industry forecasting firm determined that last year nanotech goods in the global marketplace totaled $147 billion. According to the poll, the level of U.S. public awareness about nanotechnology has not changed measurably since 2004 when Hart Research conducted the first poll on the topic on behalf of the PEN. Project on Emerging Nanotechnologies | |||||||||||||||||||||
|
Related Synthetic Biology Current Events and Synthetic Biology News Articles Synthetic virus supports a bat origin for SARS SARS - severe acute respiratory syndrome - alarmed the world five years ago as the first global pandemic of the 21st century. The coronavirus (SARS-CoV) that sickened more than 8,000 people - and killed nearly 800 of them - may have originated in bats, but the actual animal source is not known. Systems biology brings hope of speeding up drug development Almost every day brings news of an apparent breakthrough against cancer, infectious diseases, or metabolic conditions like diabetes, but these rarely translate into effective therapies or drugs, and even if they do clinical development usually takes well over a decade. Credit crunch threatens new medicines The global financial crisis could seriously delay the discovery and production of many new life-saving medicines, warns a major international conference today. Better beer: college team creating anticancer brew College students often spend their free time thinking about beer, but a group of Rice University students are taking it to the next level. They're using genetic engineering to create beer that contains resveratrol, a chemical in wine that's been shown to reduce cancer and heart disease in lab animals. Tips on how to build a better home for biological parts Researchers at the Virginia Bioinformatics Institute (VBI) at Virginia Tech have compiled a series of guidelines that should help researchers in their efforts to design, develop and manage next-generation databases of biological parts. Novel living system recreates predator-prey interaction The hunter-versus-hunted phenomenon exemplified by a pack of lionesses chasing down a lonely gazelle has been recreated in a Petri dish with lowly bacteria. Scientists synthesize memory in yeast cells Harvard Medical School researchers have successfully synthesized a DNA-based memory loop in yeast cells, findings that mark a significant step forward in the emerging field of synthetic biology. Boston Univeristy bioengineers devise 'dimmer swith' to regulate gene expression in mammal cells Three Boston University biomedical engineers have created a genetic dimmer switch that can be used to turn on, shut off, or partially activate a gene's function. Life elsewhere in Solar System could be different from life as we know it The search for life elsewhere in the solar system and beyond should include efforts to detect what scientists sometimes refer to as "weird" life -- that is, life with an alternative biochemistry to that of life on Earth -- says a new report from the National Research Council. Scientists call for global push to advance research in synthetic biology With research backgrounds ranging from materials engineering to molecular biophysics, seventeen leading scientists issued a statement today announcing that, much as the discovery of DNA and creation of the transistor revolutionized science, there is a new scientific field on the brink of revolutionizing our approach to problems ranging from eco-safe energy to outbreaks of malaria. More Synthetic Biology Current Events and Synthetic Biology News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||